US2018171056A1PendingUtilityA1

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

Assignee: UNIV WASHINGTONPriority: May 13, 2008Filed: Nov 30, 2017Published: Jun 21, 2018
Est. expiryMay 13, 2028(~1.8 yrs left)· nominal 20-yr term from priority
A61P 7/02A61P 37/06A61P 7/00A61P 9/00A61P 25/28A61P 29/00A61P 31/00A61P 35/00A61P 25/00A61P 3/00A61P 21/00C08F 220/10C12N 2310/351C12N 2310/315C12N 2320/32C12N 15/111A61K 31/713C12N 15/87C08F 299/00C08F 293/00A61K 47/58A61K 48/00A61K 47/32C08F 293/005C12N 2310/14C12N 15/113C07K 2319/10
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are copolymers, and methods of making and utilizing such copolymers. Such copolymers have at least two blocks: a first block that has at least one unit that is hydrophilic at physiologic pH, and a second block that has hydrophobic groups. This second block further has at least one unit with a group that is anionic at about physiologic pH. The described copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the copolymer is endosomolytic.

Claims

exact text as granted — not AI-modified
1 - 39 . (canceled) 
     
     
         40 . An endosomolytic copolymer comprising:
 (a) a first block, the first block being a hydrophilic block comprising a first chargeable species that is cationic at about neutral pH;   (b) a second block, the second block being a membrane destabilizing hydrophobic block comprising:
 (i) a second chargeable species that is anionic at about neutral pH; and 
 (ii) a third chargeable species that is cationic at about neutral pH; and 
   (c) an oligonucleotide associated with the first block;   wherein the first chargeable species is present on a first constitutional unit, the second chargeable species is present on a second constitutional unit, and the third chargeable species is present on a third constitutional unit.   
     
     
         41 . The copolymer of  claim 40 , wherein the copolymer is a diblock copolymer. 
     
     
         42 . The copolymer of  claim 40 , wherein the first chargeable species is selected from the group consisting of amino, alkylamino, guanidine, imidazole, and pyridyl. 
     
     
         43 . The copolymer of  claim 42 , wherein the first constitutional unit is a residue of dialkylaminoalkylmethacrylate (DMAEMA). 
     
     
         44 . The copolymer of  claim 40 , wherein the second chargeable species is selected from the group consisting of carboxylate, boronate, phosphonate, and phosphate. 
     
     
         45 . The copolymer of  claim 44 , wherein the second constitutional unit is a residue of ethyl acrylic acid or propyl acrylic acid. 
     
     
         46 . The copolymer of  claim 40 , wherein the third chargeable species is selected from the group consisting of amino, alkylamino, guanidine, imidazole, and pyridyl. 
     
     
         47 . The copolymer of  claim 46 , wherein the third constitutional unit is a residue of dialkylaminoalkylmethacrylate (DMAEMA). 
     
     
         48 . The copolymer of  claim 40 , wherein the second constitutional unit is a residue of propyl acrylic acid (PAA) and the third constitutional unit is a residue of dialkylaminoalkylmethacrylate (DMAEMA), and
 wherein the second block further comprises a residue of butyl methacrylate (BMA) as a fourth constitutional unit.   
     
     
         49 . The copolymer of  claim 40 , comprising the chemical Formula II: 
       
         
           
           
               
               
           
         
         wherein 
         A 0 , A 1 , A 2 , A 3  and A 4  are selected from the group consisting of —C—C—, —C(O)(C) a C(O)O—, and —O(C) a C(O)—, wherein a is 1-4; 
         Y 0  and Y 4  are independently selected from the group consisting of hydrogen, -(1C-10C)alkyl, -(3C-6C)cycloalkyl, —O-(1C-10C)alkyl, —C(O)O(1C-10C)alkyl, —C(O)NR 6 (1C-10C), -(4C-10C)hetroaryl and -(6C-10C)aryl, any of which is optionally substituted with one or more fluorine groups; 
         Y 1  and Y 2  are independently selected from the group consisting of a covalent bond, -(1C-10C)alkyl-, —C(O)O(2C-10C)alkyl-, —OC(O)(1C-10C)alkyl-, —O(2C-10C)alkyl-, —S(2C-10C)alkyl-, —C(O)NR 6 (2C-10C)alkyl-, -(4C-10C)hetroaryl- and -(6C-10C)aryl-; 
         Y 3  is selected from the group consisting of a covalent bond, -(1C-10C)alkyl-, -(4C-10C)hetroaryl- and -(6C-10C)aryl-; wherein tetravalent carbon atoms of A 0 -A 4  that are not fully substituted with R 1 -R 5  and Y 0 —Y 4  are completed with an appropriate number of hydrogen atoms; 
         R 1 , R 2 , R 3 , R 4 , R 5 , and R 6  are independently selected from the group consisting of hydrogen, —CN, alkyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl and heteroaryl, any of which may be optionally substituted with one or more fluorine atoms; 
         Q 1  and Q 2  are residues which are positively charged at normal physiological pH; 
         Q 3  is a residue which is negatively charged at normal physiological pH, but undergoes protonation at lower pH; 
         m is a mole fraction of 0 to 0.49; 
         n is a mole fraction of 0.51 to 1.0; wherein m+n=1 
         p is a mole fraction of 0.2 to 0.5; 
         q is a mole fraction of 0.2 to 0.5; wherein p is substantially the same as q; 
         r is a mole fraction of 0 to 0.6; wherein p+q+r=1 
         v is from 1 to 25 kDa; and, 
         w is from 1 to 50 kDa. 
       
     
     
         50 . The copolymer of  claim 49 , wherein m is 0. 
     
     
         51 . The copolymer of  claim 49 , wherein R 2 -A 1 -Y 1 -Q 1  is a residue of a C1-6 dialkylamino(C1-6)alkylmethacrylate, C1-6 alkylamino(C1-6)alkylmethacrylate, amino(C1-6)alkylacrylate, C1-6 dialkylamino(C1-6)alkylethacrylate, C1-6 alkylamino(C1-6)alkylethacrylate, amino(C1-6)alkylethacrylate, C1-6 dialkylamino(C1-6)alkylacrylate, C1-6 alkyl amino(C1-6)alkylacrylate, or amino(C1-6)alkylacrylate. 
     
     
         52 . The copolymer of  claim 51 , wherein R 2 -A 1 -Y 1 -Q 1  is a residue of dialkylaminoalkylmethacrylate (DMAEMA). 
     
     
         53 . The copolymer of  claim 49 , wherein R 3 -A 2 -Y 2 -Q 2  is a residue of a C1-6 dialkylamino(C1-6)alkylmethacrylate, C1-6 alkylamino(C1-6)alkylmethacrylate, amino(C1-6)alkylacrylate, C1-6 dialkylamino(C1-6)alkylethacrylate, C1-6 alkylamino(C1-6)alkylethacrylate, amino(C1-6)alkylethacrylate, C1-6 dialkylamino(C1-6)alkylacrylate, C1-6 alkyl amino(C1-6)alkylacrylate, or amino(C1-6)alkylacrylate. 
     
     
         54 . The copolymer of  claim 53 , wherein R 3 -A 2 -Y 2 -Q 2  is a residue of dialkylaminoalkylmethacrylate (DMAEMA). 
     
     
         55 . The copolymer of  claim 49 , wherein R 4 -A 3 -Y 3 -Q 3  is a residue of ethyl acrylic acid or propyl acrylic acid. 
     
     
         56 . The copolymer of  claim 49 , wherein R 5 -A 4 -Y 4  is a residue of a C1-6 alkylacrylate, C1-C6 alkylmethacrylate, or C1-C6 alkylethacrylate. 
     
     
         57 . The copolymer of  claim 49 , comprising the chemical Formula IV3 or Formula IV5:
   [DMAEMA] v -[B p -/-P q -/-D r ] w   (IV3)
     [PEGMA m -/-DMAEMA n ] v -[B p -/-P q -/-Dr] w   (IV5)
   wherein B is butyl methacrylate residue; P is propyl acrylic acid residue; D and DMAEMA are dimethylaminoethyl methacrylate residue; and PEGMA is polyethyleneglycol methacrylate residue.   
     
     
         58 . The copolymer of  claim 40 , wherein the copolymer comprises a targeting moiety. 
     
     
         59 . The copolymer of  claim 40 , wherein the oligonucleotide is selected from the group consisting of an siRNA, a microRNA (miRNA), a short hairpin RNA (shRNA), an asymmetrical interfering RNA (aiRNA), and a dicer substrate.

Join the waitlist — get patent alerts

Track US2018171056A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.